Khorashad et al., (2013) analyzed BCR-ABL kinase domain mutations in 1,700 samples by direct DNA sequencing and found that 11.4% CML patient samples harbored ≥2 mutations. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.